A new paradigm for the management of ATL.
作者信息
Taylor Graham P, Cook Lucy B
机构信息
Section of Virology, Department on Infectious Disease, Imperial College London, London, UK.
National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, London, UK.
出版信息
Br J Haematol. 2022 Sep;198(6):941-942. doi: 10.1111/bjh.18363. Epub 2022 Jul 15.
Abstract
摘要
相似文献
1
A new paradigm for the management of ATL.成人T细胞白血病/淋巴瘤（ATL）治疗的新范式
Br J Haematol. 2022 Sep;198(6):941-942. doi: 10.1111/bjh.18363. Epub 2022 Jul 15.
2
Human T-lymphotropic virus type I proviral loads in patients with adult T-cell leukemia-lymphoma: Comparison between cutaneous type and other subtypes.成人T细胞白血病淋巴瘤患者中I型人嗜T淋巴细胞病毒前病毒载量：皮肤型与其他亚型的比较。
J Dermatol. 2015 Dec;42(12):1143-8. doi: 10.1111/1346-8138.13004. Epub 2015 Jun 30.
3
Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research.人类 T 细胞嗜淋巴细胞病毒 I 型相关成人 T 细胞白血病/淋巴瘤：临床研究的新方向。
Clin Cancer Res. 2014 Oct 15;20(20):5217-25. doi: 10.1158/1078-0432.CCR-14-0572.
4
RETINAL MANIFESTATIONS IN ADULT T-CELL LEUKEMIA/LYMPHOMA RELATED TO INFECTION BY THE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1.成人T细胞白血病/淋巴瘤中与人类T细胞嗜淋巴细胞病毒1型感染相关的视网膜表现
Retina. 2016 Jul;36(7):1364-71. doi: 10.1097/IAE.0000000000000927.
5
Adult T-cell leukemia-lymphoma in a pregnant woman diagnosed as a human T-cell lymphotropic virus type 1 carrier.一名被诊断为人T细胞嗜淋巴病毒1型携带者的孕妇患成人T细胞白血病-淋巴瘤。
J Obstet Gynaecol Res. 2016 Mar;42(3):336-40. doi: 10.1111/jog.12904. Epub 2015 Dec 10.
6
The incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type 1 carriers in Japan.日本1型人类嗜T淋巴细胞病毒携带者中成人T细胞白血病/淋巴瘤的发病率。
Leuk Lymphoma. 2015 Jun;56(6):1806-12. doi: 10.3109/10428194.2014.964700. Epub 2015 Jan 21.
7
A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients.由人类嗜T细胞病毒1型Tax特异性细胞毒性T细胞在HLA-A24:02阳性无症状携带者和成人T细胞白血病/淋巴瘤患者中选择的独特T细胞受体氨基酸序列。
J Virol. 2017 Sep 12;91(19). doi: 10.1128/JVI.00974-17. Print 2017 Oct 1.
8
Adult T-cell leukemia-lymphoma.成人T细胞白血病-淋巴瘤
Hematology. 2012 Apr;17 Suppl 1:S32-5. doi: 10.1179/102453312X13336169155330.
9
10
[Current status and future directions of ATL].
Rinsho Ketsueki. 2018;59(10):2136-2145. doi: 10.11406/rinketsu.59.2136.
引用本文的文献
1
Development of a silicon phthalocyanine analogue for near-infrared photoimmunotherapy and its application to HTLV-1-infected leukemic cells.用于近红外光免疫疗法的硅酞菁类似物的研发及其在人嗜T淋巴细胞病毒1型感染的白血病细胞中的应用。
RSC Chem Biol. 2025 Aug 5. doi: 10.1039/d5cb00150a.
2
HTLV-1 persistence and the oncogenesis of adult T-cell leukemia/lymphoma.HTLV-1 持续感染与成人 T 细胞白血病/淋巴瘤的发生。
Blood. 2023 May 11;141(19):2299-2306. doi: 10.1182/blood.2022019332.
本文引用的文献
1
Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study.通过增加异基因造血干细胞移植（allo-HCT）的使用来提高侵袭性成人T细胞白血病（ATL）患者的生存率：一项前瞻性观察研究。
Blood Adv. 2021 Oct 26;5(20):4156-4166. doi: 10.1182/bloodadvances.2021004932.
2
Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma.成人T细胞白血病/淋巴瘤中TP53突变的临床意义
Br J Haematol. 2021 Nov;195(4):571-584. doi: 10.1111/bjh.17749. Epub 2021 Aug 17.
3
A Phase I/II Multicenter Trial of HLA-Haploidentical PBSCT with PTCy for Aggressive Adult T Cell Leukemia/Lymphoma.一项 HLA 单倍体相合 PBSCT 联合 PTCy 治疗侵袭性成人 T 细胞白血病/淋巴瘤的 I/II 期多中心试验。
Transplant Cell Ther. 2021 Nov;27(11):928.e1-928.e7. doi: 10.1016/j.jtct.2021.07.010. Epub 2021 Jul 15.
4
Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.日本成人 T 细胞白血病/淋巴瘤患者的预后：一项基于全国医院的研究。
Cancer Sci. 2020 Dec;111(12):4567-4580. doi: 10.1111/cas.14658. Epub 2020 Oct 21.
5
Molecular remissions are observed in chronic adult T-cell leukemia/lymphoma in patients treated with mogamulizumab.在用莫加莫珠单抗治疗的慢性成人T细胞白血病/淋巴瘤患者中观察到分子缓解。
Haematologica. 2019 Dec;104(12):e566-e569. doi: 10.3324/haematol.2019.219253. Epub 2019 Apr 19.
6
Mogamulizumab investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma.莫格利珠单抗治疗复发/难治性成人 T 细胞白血病/淋巴瘤的化疗方案选择。
Haematologica. 2019 May;104(5):993-1003. doi: 10.3324/haematol.2018.205096. Epub 2018 Dec 20.
7
A Multicenter Retrospective Study of Mogamulizumab Efficacy in Adult T-Cell Leukemia/Lymphoma.莫加莫拉单抗治疗成人T细胞白血病/淋巴瘤疗效的多中心回顾性研究。
Clin Lymphoma Myeloma Leuk. 2017 Jan;17(1):23-30.e2. doi: 10.1016/j.clml.2016.09.009. Epub 2016 Sep 17.
8
Treatment and survival among 1594 patients with ATL.1594 例 ATL 患者的治疗和生存情况。
Blood. 2015 Dec 10;126(24):2570-7. doi: 10.1182/blood-2015-03-632489. Epub 2015 Sep 11.
9
Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.在新诊断的侵袭性成人T细胞白血病-淋巴瘤中，单独使用剂量强化化疗或联合莫加莫拉单抗治疗：一项随机II期研究。
Br J Haematol. 2015 Jun;169(5):672-82. doi: 10.1111/bjh.13338. Epub 2015 Mar 2.
10
Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study.去岩藻糖基化抗 CCR4 单克隆抗体（KW-0761）治疗复发成人 T 细胞白血病/淋巴瘤：一项多中心 II 期研究。
J Clin Oncol. 2012 Mar 10;30(8):837-42. doi: 10.1200/JCO.2011.37.3472. Epub 2012 Feb 6.
Zotero 插件